Get the Stockscreener App
7.6598
15.29%
0.9898
Nutriband Inc stock is traded at $7.6598, with a volume of 846.94K.
It is up +15.29% in the last 24 hours and up +72.81% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$6.67
Open:
$7.4
24h Volume:
846.94K
Relative Volume:
4.85
Market Cap:
$74.08M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-11.43
EPS:
-0.67
Net Cash Flow:
$-3.64M
1W Performance:
-7.24%
1M Performance:
+72.81%
6M Performance:
+45.64%
1Y Performance:
+201.57%
1-Day Range:
$7.40
$8.86
1-Week Range:
$6.39
$8.86
52-Week Range:
$2.22
$11.78
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
7.69 | 74.08M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.55 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.08 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
653.00 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.69 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.72 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Nutriband secures US patent for abuse deterrent patch - Investing.com
Nutriband Receives Notice Of Allowance For New U.S. Patent - GlobeNewswire
Game-Changing Patent Win: Nutriband's Abuse-Proof Fentanyl Patch Could Hit $200M in Sales - StockTitan
Nutriband Inc (NTRB) Shares Decline Despite Market Challenges - The News Heater
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology - ACCESS Newswire
Nutriband Inc. (NASDAQ:NTRB) Short Interest Down 24.4% in January - MarketBeat
Why Nutriband Inc (NTRB) Is Skyrocketing So Far In 2025 - Yahoo Finance
(NTRB) Proactive Strategies - Stock Traders Daily
NutriBand Shareholders Approve Key Proposals at Annual Meeting - MSN
NutriBand Shareholders Approve Key Proposals at Annual Meeting By Investing.com - Investing.com UK
Nutriband (NASDAQ:NTRBW) Stock Price Down 10.7% – Time to Sell? - Defense World
Nutriband Inc Joins Webull Corporate Communications Service Platform - ACCESS Newswire
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors - ACCESS Newswire
Noble Financial Predicts Nutriband FY2025 Earnings - Defense World
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth - MSN
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 - ACCESS Newswire
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 - ACCESS Newswire
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - ACCESS Newswire
Analysts Set Expectations for Nutriband FY2025 Earnings - MarketBeat
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth By Investing.com - Investing.com South Africa
Noble Financial Begins Coverage on Nutriband (NASDAQ:NTRB) - MarketBeat
Noble Capital sets Nutriband stock Outperform with $13 target - MSN
Noble Capital sets Nutriband stock Outperform with $13 target By Investing.com - Investing.com Australia
Noble Capital Markets Initiates Coverage of Nutriband (NTRB) with Outperform Recommendation - MSN
Most Shareholders Will Probably Find That The Compensation For Nutriband Inc.'s (NASDAQ:NTRB) CEO Is Reasonable - Simply Wall St
Geode Capital Management LLC Has $351,000 Position in Nutriband Inc. (NASDAQ:NTRB) - Defense World
Shareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years ago - Yahoo Finance
Investors ignore increasing losses at Nutriband (NASDAQ:NTRB) as stock jumps 19% this past week - Simply Wall St
Nutriband Inc. Extends Chinese Patent to Macao for AVERSA™ Abuse Deterrent Transdermal Technology - Defense World
Nutriband Issues Letter to Shareholders - GlobeNewswire
Nutriband Expands AVERSA™ Patent to Macao - TipRanks
Nutriband extends Chinese patent to Macao for AVERSA technology - Yahoo Finance
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband (NASDAQ:NTRB) Trading 1.5% Higher – Time to Buy? - Defense World
Nutriband Reports Record Q3 Revenue, Up 51% YOY; Advances AVERSA Fentanyl Development | NTRBW Stock News - StockTitan
Nutriband Reports Record Q3 Revenue, Up 51% YOY; Advances AVERSA Fentanyl Development | NTRB Stock News - StockTitan
Nutriband Inc. Quarterly Report Highlights Record Revenue - GlobeNewswire
Nutriband Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2024 - Marketscreener.com
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th - The Manila Times
Nutriband to Showcase Revolutionary Abuse-Deterrent Technology at Noble Conference - StockTitan
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - Yahoo Finance
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - The Manila Times
Nutriband Secures Hong Kong Patent for Abuse-Deterrent Patch Technology, Eyes $200M Market | NTRB Stock News - StockTitan
(NTRB) Technical Pivots with Risk Controls - Stock Traders Daily
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):